Medical Care
Global HMGB1 Antibody Market Research Report 2025
- May 12, 25
- ID: 234918
- Pages: 127
- Figures: 122
- Views: 8
The global market for HMGB1 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
HMGB1 Antibody can be used in a variety of scientific applications, including western blotting, immunohistochemistry, immunocytochemistry, immunoprecipitation, and ELISA. These antibodies target MMP13 in human, mouse, rat, rabbit and pig samples.
Growing patient base, launch of novel HMGB1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue of the HMGB1 antibody market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for HMGB1 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HMGB1 Antibody.
The HMGB1 Antibody market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HMGB1 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HMGB1 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Thermo Fisher Scientific
Novus Biologicals
Abbexa
LifeSpan BioSciences
GeneTex
Bio-Rad
Bioss
Chondrex
Biorbyt
Abnova Corporation
Abeomics
Abcam
RayBiotech
EpiGentek
NSJ Bioreagents
ProSci
BioLegend
HUABIO
Elabscience Biotechnology
Enzo Life Sciences
AssayPro
Cell Signaling Technology
R and D Systems
Aviva Systems Biology
Beijing Solarbio
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Western Blot (WB)
Immunocytochemistry (ICC)
ELISA
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HMGB1 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HMGB1 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
HMGB1 Antibody can be used in a variety of scientific applications, including western blotting, immunohistochemistry, immunocytochemistry, immunoprecipitation, and ELISA. These antibodies target MMP13 in human, mouse, rat, rabbit and pig samples.
Growing patient base, launch of novel HMGB1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue of the HMGB1 antibody market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for HMGB1 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HMGB1 Antibody.
The HMGB1 Antibody market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HMGB1 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HMGB1 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Thermo Fisher Scientific
Novus Biologicals
Abbexa
LifeSpan BioSciences
GeneTex
Bio-Rad
Bioss
Chondrex
Biorbyt
Abnova Corporation
Abeomics
Abcam
RayBiotech
EpiGentek
NSJ Bioreagents
ProSci
BioLegend
HUABIO
Elabscience Biotechnology
Enzo Life Sciences
AssayPro
Cell Signaling Technology
R and D Systems
Aviva Systems Biology
Beijing Solarbio
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Western Blot (WB)
Immunocytochemistry (ICC)
ELISA
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HMGB1 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HMGB1 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 HMGB1 Antibody Market Overview
1.1 Product Definition
1.2 HMGB1 Antibody by Type
1.2.1 Global HMGB1 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 HMGB1 Antibody by Application
1.3.1 Global HMGB1 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Western Blot (WB)
1.3.5 Immunocytochemistry (ICC)
1.3.6 ELISA
1.3.7 Others
1.4 Global HMGB1 Antibody Market Size Estimates and Forecasts
1.4.1 Global HMGB1 Antibody Revenue 2020-2031
1.4.2 Global HMGB1 Antibody Sales 2020-2031
1.4.3 Global HMGB1 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 HMGB1 Antibody Market Competition by Manufacturers
2.1 Global HMGB1 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global HMGB1 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global HMGB1 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of HMGB1 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HMGB1 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HMGB1 Antibody, Product Type & Application
2.7 Global Key Manufacturers of HMGB1 Antibody, Date of Enter into This Industry
2.8 Global HMGB1 Antibody Market Competitive Situation and Trends
2.8.1 Global HMGB1 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HMGB1 Antibody Players Market Share by Revenue
2.8.3 Global HMGB1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HMGB1 Antibody Market Scenario by Region
3.1 Global HMGB1 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global HMGB1 Antibody Sales by Region: 2020-2031
3.2.1 Global HMGB1 Antibody Sales by Region: 2020-2025
3.2.2 Global HMGB1 Antibody Sales by Region: 2026-2031
3.3 Global HMGB1 Antibody Revenue by Region: 2020-2031
3.3.1 Global HMGB1 Antibody Revenue by Region: 2020-2025
3.3.2 Global HMGB1 Antibody Revenue by Region: 2026-2031
3.4 North America HMGB1 Antibody Market Facts & Figures by Country
3.4.1 North America HMGB1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America HMGB1 Antibody Sales by Country (2020-2031)
3.4.3 North America HMGB1 Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe HMGB1 Antibody Market Facts & Figures by Country
3.5.1 Europe HMGB1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe HMGB1 Antibody Sales by Country (2020-2031)
3.5.3 Europe HMGB1 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HMGB1 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific HMGB1 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific HMGB1 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific HMGB1 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HMGB1 Antibody Market Facts & Figures by Country
3.7.1 Latin America HMGB1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America HMGB1 Antibody Sales by Country (2020-2031)
3.7.3 Latin America HMGB1 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa HMGB1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa HMGB1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa HMGB1 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa HMGB1 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HMGB1 Antibody Sales by Type (2020-2031)
4.1.1 Global HMGB1 Antibody Sales by Type (2020-2025)
4.1.2 Global HMGB1 Antibody Sales by Type (2026-2031)
4.1.3 Global HMGB1 Antibody Sales Market Share by Type (2020-2031)
4.2 Global HMGB1 Antibody Revenue by Type (2020-2031)
4.2.1 Global HMGB1 Antibody Revenue by Type (2020-2025)
4.2.2 Global HMGB1 Antibody Revenue by Type (2026-2031)
4.2.3 Global HMGB1 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global HMGB1 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global HMGB1 Antibody Sales by Application (2020-2031)
5.1.1 Global HMGB1 Antibody Sales by Application (2020-2025)
5.1.2 Global HMGB1 Antibody Sales by Application (2026-2031)
5.1.3 Global HMGB1 Antibody Sales Market Share by Application (2020-2031)
5.2 Global HMGB1 Antibody Revenue by Application (2020-2031)
5.2.1 Global HMGB1 Antibody Revenue by Application (2020-2025)
5.2.2 Global HMGB1 Antibody Revenue by Application (2026-2031)
5.2.3 Global HMGB1 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global HMGB1 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck HMGB1 Antibody Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Scientific HMGB1 Antibody Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Novus Biologicals
6.3.1 Novus Biologicals Company Information
6.3.2 Novus Biologicals Description and Business Overview
6.3.3 Novus Biologicals HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novus Biologicals HMGB1 Antibody Product Portfolio
6.3.5 Novus Biologicals Recent Developments/Updates
6.4 Abbexa
6.4.1 Abbexa Company Information
6.4.2 Abbexa Description and Business Overview
6.4.3 Abbexa HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbexa HMGB1 Antibody Product Portfolio
6.4.5 Abbexa Recent Developments/Updates
6.5 LifeSpan BioSciences
6.5.1 LifeSpan BioSciences Company Information
6.5.2 LifeSpan BioSciences Description and Business Overview
6.5.3 LifeSpan BioSciences HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 LifeSpan BioSciences HMGB1 Antibody Product Portfolio
6.5.5 LifeSpan BioSciences Recent Developments/Updates
6.6 GeneTex
6.6.1 GeneTex Company Information
6.6.2 GeneTex Description and Business Overview
6.6.3 GeneTex HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GeneTex HMGB1 Antibody Product Portfolio
6.6.5 GeneTex Recent Developments/Updates
6.7 Bio-Rad
6.7.1 Bio-Rad Company Information
6.7.2 Bio-Rad Description and Business Overview
6.7.3 Bio-Rad HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio-Rad HMGB1 Antibody Product Portfolio
6.7.5 Bio-Rad Recent Developments/Updates
6.8 Bioss
6.8.1 Bioss Company Information
6.8.2 Bioss Description and Business Overview
6.8.3 Bioss HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bioss HMGB1 Antibody Product Portfolio
6.8.5 Bioss Recent Developments/Updates
6.9 Chondrex
6.9.1 Chondrex Company Information
6.9.2 Chondrex Description and Business Overview
6.9.3 Chondrex HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Chondrex HMGB1 Antibody Product Portfolio
6.9.5 Chondrex Recent Developments/Updates
6.10 Biorbyt
6.10.1 Biorbyt Company Information
6.10.2 Biorbyt Description and Business Overview
6.10.3 Biorbyt HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Biorbyt HMGB1 Antibody Product Portfolio
6.10.5 Biorbyt Recent Developments/Updates
6.11 Abnova Corporation
6.11.1 Abnova Corporation Company Information
6.11.2 Abnova Corporation Description and Business Overview
6.11.3 Abnova Corporation HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Abnova Corporation HMGB1 Antibody Product Portfolio
6.11.5 Abnova Corporation Recent Developments/Updates
6.12 Abeomics
6.12.1 Abeomics Company Information
6.12.2 Abeomics Description and Business Overview
6.12.3 Abeomics HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Abeomics HMGB1 Antibody Product Portfolio
6.12.5 Abeomics Recent Developments/Updates
6.13 Abcam
6.13.1 Abcam Company Information
6.13.2 Abcam Description and Business Overview
6.13.3 Abcam HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Abcam HMGB1 Antibody Product Portfolio
6.13.5 Abcam Recent Developments/Updates
6.14 RayBiotech
6.14.1 RayBiotech Company Information
6.14.2 RayBiotech Description and Business Overview
6.14.3 RayBiotech HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 RayBiotech HMGB1 Antibody Product Portfolio
6.14.5 RayBiotech Recent Developments/Updates
6.15 EpiGentek
6.15.1 EpiGentek Company Information
6.15.2 EpiGentek Description and Business Overview
6.15.3 EpiGentek HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 EpiGentek HMGB1 Antibody Product Portfolio
6.15.5 EpiGentek Recent Developments/Updates
6.16 NSJ Bioreagents
6.16.1 NSJ Bioreagents Company Information
6.16.2 NSJ Bioreagents Description and Business Overview
6.16.3 NSJ Bioreagents HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 NSJ Bioreagents HMGB1 Antibody Product Portfolio
6.16.5 NSJ Bioreagents Recent Developments/Updates
6.17 ProSci
6.17.1 ProSci Company Information
6.17.2 ProSci Description and Business Overview
6.17.3 ProSci HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 ProSci HMGB1 Antibody Product Portfolio
6.17.5 ProSci Recent Developments/Updates
6.18 BioLegend
6.18.1 BioLegend Company Information
6.18.2 BioLegend Description and Business Overview
6.18.3 BioLegend HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 BioLegend HMGB1 Antibody Product Portfolio
6.18.5 BioLegend Recent Developments/Updates
6.19 HUABIO
6.19.1 HUABIO Company Information
6.19.2 HUABIO Description and Business Overview
6.19.3 HUABIO HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 HUABIO HMGB1 Antibody Product Portfolio
6.19.5 HUABIO Recent Developments/Updates
6.20 Elabscience Biotechnology
6.20.1 Elabscience Biotechnology Company Information
6.20.2 Elabscience Biotechnology Description and Business Overview
6.20.3 Elabscience Biotechnology HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Elabscience Biotechnology HMGB1 Antibody Product Portfolio
6.20.5 Elabscience Biotechnology Recent Developments/Updates
6.21 Enzo Life Sciences
6.21.1 Enzo Life Sciences Company Information
6.21.2 Enzo Life Sciences Description and Business Overview
6.21.3 Enzo Life Sciences HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Enzo Life Sciences HMGB1 Antibody Product Portfolio
6.21.5 Enzo Life Sciences Recent Developments/Updates
6.22 AssayPro
6.22.1 AssayPro Company Information
6.22.2 AssayPro Description and Business Overview
6.22.3 AssayPro HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.22.4 AssayPro HMGB1 Antibody Product Portfolio
6.22.5 AssayPro Recent Developments/Updates
6.23 Cell Signaling Technology
6.23.1 Cell Signaling Technology Company Information
6.23.2 Cell Signaling Technology Description and Business Overview
6.23.3 Cell Signaling Technology HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Cell Signaling Technology HMGB1 Antibody Product Portfolio
6.23.5 Cell Signaling Technology Recent Developments/Updates
6.24 R and D Systems
6.24.1 R and D Systems Company Information
6.24.2 R and D Systems Description and Business Overview
6.24.3 R and D Systems HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.24.4 R and D Systems HMGB1 Antibody Product Portfolio
6.24.5 R and D Systems Recent Developments/Updates
6.25 Aviva Systems Biology
6.25.1 Aviva Systems Biology Company Information
6.25.2 Aviva Systems Biology Description and Business Overview
6.25.3 Aviva Systems Biology HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Aviva Systems Biology HMGB1 Antibody Product Portfolio
6.25.5 Aviva Systems Biology Recent Developments/Updates
6.26 Beijing Solarbio
6.26.1 Beijing Solarbio Company Information
6.26.2 Beijing Solarbio Description and Business Overview
6.26.3 Beijing Solarbio HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Beijing Solarbio HMGB1 Antibody Product Portfolio
6.26.5 Beijing Solarbio Recent Developments/Updates
6.27 Jingjie PTM BioLab
6.27.1 Jingjie PTM BioLab Company Information
6.27.2 Jingjie PTM BioLab Description and Business Overview
6.27.3 Jingjie PTM BioLab HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Jingjie PTM BioLab HMGB1 Antibody Product Portfolio
6.27.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HMGB1 Antibody Industry Chain Analysis
7.2 HMGB1 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HMGB1 Antibody Production Mode & Process Analysis
7.4 HMGB1 Antibody Sales and Marketing
7.4.1 HMGB1 Antibody Sales Channels
7.4.2 HMGB1 Antibody Distributors
7.5 HMGB1 Antibody Customer Analysis
8 HMGB1 Antibody Market Dynamics
8.1 HMGB1 Antibody Industry Trends
8.2 HMGB1 Antibody Market Drivers
8.3 HMGB1 Antibody Market Challenges
8.4 HMGB1 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 HMGB1 Antibody by Type
1.2.1 Global HMGB1 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 HMGB1 Antibody by Application
1.3.1 Global HMGB1 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Western Blot (WB)
1.3.5 Immunocytochemistry (ICC)
1.3.6 ELISA
1.3.7 Others
1.4 Global HMGB1 Antibody Market Size Estimates and Forecasts
1.4.1 Global HMGB1 Antibody Revenue 2020-2031
1.4.2 Global HMGB1 Antibody Sales 2020-2031
1.4.3 Global HMGB1 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 HMGB1 Antibody Market Competition by Manufacturers
2.1 Global HMGB1 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global HMGB1 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global HMGB1 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of HMGB1 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HMGB1 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HMGB1 Antibody, Product Type & Application
2.7 Global Key Manufacturers of HMGB1 Antibody, Date of Enter into This Industry
2.8 Global HMGB1 Antibody Market Competitive Situation and Trends
2.8.1 Global HMGB1 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HMGB1 Antibody Players Market Share by Revenue
2.8.3 Global HMGB1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HMGB1 Antibody Market Scenario by Region
3.1 Global HMGB1 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global HMGB1 Antibody Sales by Region: 2020-2031
3.2.1 Global HMGB1 Antibody Sales by Region: 2020-2025
3.2.2 Global HMGB1 Antibody Sales by Region: 2026-2031
3.3 Global HMGB1 Antibody Revenue by Region: 2020-2031
3.3.1 Global HMGB1 Antibody Revenue by Region: 2020-2025
3.3.2 Global HMGB1 Antibody Revenue by Region: 2026-2031
3.4 North America HMGB1 Antibody Market Facts & Figures by Country
3.4.1 North America HMGB1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America HMGB1 Antibody Sales by Country (2020-2031)
3.4.3 North America HMGB1 Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe HMGB1 Antibody Market Facts & Figures by Country
3.5.1 Europe HMGB1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe HMGB1 Antibody Sales by Country (2020-2031)
3.5.3 Europe HMGB1 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HMGB1 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific HMGB1 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific HMGB1 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific HMGB1 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HMGB1 Antibody Market Facts & Figures by Country
3.7.1 Latin America HMGB1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America HMGB1 Antibody Sales by Country (2020-2031)
3.7.3 Latin America HMGB1 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa HMGB1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa HMGB1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa HMGB1 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa HMGB1 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HMGB1 Antibody Sales by Type (2020-2031)
4.1.1 Global HMGB1 Antibody Sales by Type (2020-2025)
4.1.2 Global HMGB1 Antibody Sales by Type (2026-2031)
4.1.3 Global HMGB1 Antibody Sales Market Share by Type (2020-2031)
4.2 Global HMGB1 Antibody Revenue by Type (2020-2031)
4.2.1 Global HMGB1 Antibody Revenue by Type (2020-2025)
4.2.2 Global HMGB1 Antibody Revenue by Type (2026-2031)
4.2.3 Global HMGB1 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global HMGB1 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global HMGB1 Antibody Sales by Application (2020-2031)
5.1.1 Global HMGB1 Antibody Sales by Application (2020-2025)
5.1.2 Global HMGB1 Antibody Sales by Application (2026-2031)
5.1.3 Global HMGB1 Antibody Sales Market Share by Application (2020-2031)
5.2 Global HMGB1 Antibody Revenue by Application (2020-2031)
5.2.1 Global HMGB1 Antibody Revenue by Application (2020-2025)
5.2.2 Global HMGB1 Antibody Revenue by Application (2026-2031)
5.2.3 Global HMGB1 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global HMGB1 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck HMGB1 Antibody Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Scientific HMGB1 Antibody Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Novus Biologicals
6.3.1 Novus Biologicals Company Information
6.3.2 Novus Biologicals Description and Business Overview
6.3.3 Novus Biologicals HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novus Biologicals HMGB1 Antibody Product Portfolio
6.3.5 Novus Biologicals Recent Developments/Updates
6.4 Abbexa
6.4.1 Abbexa Company Information
6.4.2 Abbexa Description and Business Overview
6.4.3 Abbexa HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbexa HMGB1 Antibody Product Portfolio
6.4.5 Abbexa Recent Developments/Updates
6.5 LifeSpan BioSciences
6.5.1 LifeSpan BioSciences Company Information
6.5.2 LifeSpan BioSciences Description and Business Overview
6.5.3 LifeSpan BioSciences HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 LifeSpan BioSciences HMGB1 Antibody Product Portfolio
6.5.5 LifeSpan BioSciences Recent Developments/Updates
6.6 GeneTex
6.6.1 GeneTex Company Information
6.6.2 GeneTex Description and Business Overview
6.6.3 GeneTex HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GeneTex HMGB1 Antibody Product Portfolio
6.6.5 GeneTex Recent Developments/Updates
6.7 Bio-Rad
6.7.1 Bio-Rad Company Information
6.7.2 Bio-Rad Description and Business Overview
6.7.3 Bio-Rad HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio-Rad HMGB1 Antibody Product Portfolio
6.7.5 Bio-Rad Recent Developments/Updates
6.8 Bioss
6.8.1 Bioss Company Information
6.8.2 Bioss Description and Business Overview
6.8.3 Bioss HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bioss HMGB1 Antibody Product Portfolio
6.8.5 Bioss Recent Developments/Updates
6.9 Chondrex
6.9.1 Chondrex Company Information
6.9.2 Chondrex Description and Business Overview
6.9.3 Chondrex HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Chondrex HMGB1 Antibody Product Portfolio
6.9.5 Chondrex Recent Developments/Updates
6.10 Biorbyt
6.10.1 Biorbyt Company Information
6.10.2 Biorbyt Description and Business Overview
6.10.3 Biorbyt HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Biorbyt HMGB1 Antibody Product Portfolio
6.10.5 Biorbyt Recent Developments/Updates
6.11 Abnova Corporation
6.11.1 Abnova Corporation Company Information
6.11.2 Abnova Corporation Description and Business Overview
6.11.3 Abnova Corporation HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Abnova Corporation HMGB1 Antibody Product Portfolio
6.11.5 Abnova Corporation Recent Developments/Updates
6.12 Abeomics
6.12.1 Abeomics Company Information
6.12.2 Abeomics Description and Business Overview
6.12.3 Abeomics HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Abeomics HMGB1 Antibody Product Portfolio
6.12.5 Abeomics Recent Developments/Updates
6.13 Abcam
6.13.1 Abcam Company Information
6.13.2 Abcam Description and Business Overview
6.13.3 Abcam HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Abcam HMGB1 Antibody Product Portfolio
6.13.5 Abcam Recent Developments/Updates
6.14 RayBiotech
6.14.1 RayBiotech Company Information
6.14.2 RayBiotech Description and Business Overview
6.14.3 RayBiotech HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 RayBiotech HMGB1 Antibody Product Portfolio
6.14.5 RayBiotech Recent Developments/Updates
6.15 EpiGentek
6.15.1 EpiGentek Company Information
6.15.2 EpiGentek Description and Business Overview
6.15.3 EpiGentek HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 EpiGentek HMGB1 Antibody Product Portfolio
6.15.5 EpiGentek Recent Developments/Updates
6.16 NSJ Bioreagents
6.16.1 NSJ Bioreagents Company Information
6.16.2 NSJ Bioreagents Description and Business Overview
6.16.3 NSJ Bioreagents HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 NSJ Bioreagents HMGB1 Antibody Product Portfolio
6.16.5 NSJ Bioreagents Recent Developments/Updates
6.17 ProSci
6.17.1 ProSci Company Information
6.17.2 ProSci Description and Business Overview
6.17.3 ProSci HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 ProSci HMGB1 Antibody Product Portfolio
6.17.5 ProSci Recent Developments/Updates
6.18 BioLegend
6.18.1 BioLegend Company Information
6.18.2 BioLegend Description and Business Overview
6.18.3 BioLegend HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 BioLegend HMGB1 Antibody Product Portfolio
6.18.5 BioLegend Recent Developments/Updates
6.19 HUABIO
6.19.1 HUABIO Company Information
6.19.2 HUABIO Description and Business Overview
6.19.3 HUABIO HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 HUABIO HMGB1 Antibody Product Portfolio
6.19.5 HUABIO Recent Developments/Updates
6.20 Elabscience Biotechnology
6.20.1 Elabscience Biotechnology Company Information
6.20.2 Elabscience Biotechnology Description and Business Overview
6.20.3 Elabscience Biotechnology HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Elabscience Biotechnology HMGB1 Antibody Product Portfolio
6.20.5 Elabscience Biotechnology Recent Developments/Updates
6.21 Enzo Life Sciences
6.21.1 Enzo Life Sciences Company Information
6.21.2 Enzo Life Sciences Description and Business Overview
6.21.3 Enzo Life Sciences HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Enzo Life Sciences HMGB1 Antibody Product Portfolio
6.21.5 Enzo Life Sciences Recent Developments/Updates
6.22 AssayPro
6.22.1 AssayPro Company Information
6.22.2 AssayPro Description and Business Overview
6.22.3 AssayPro HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.22.4 AssayPro HMGB1 Antibody Product Portfolio
6.22.5 AssayPro Recent Developments/Updates
6.23 Cell Signaling Technology
6.23.1 Cell Signaling Technology Company Information
6.23.2 Cell Signaling Technology Description and Business Overview
6.23.3 Cell Signaling Technology HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Cell Signaling Technology HMGB1 Antibody Product Portfolio
6.23.5 Cell Signaling Technology Recent Developments/Updates
6.24 R and D Systems
6.24.1 R and D Systems Company Information
6.24.2 R and D Systems Description and Business Overview
6.24.3 R and D Systems HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.24.4 R and D Systems HMGB1 Antibody Product Portfolio
6.24.5 R and D Systems Recent Developments/Updates
6.25 Aviva Systems Biology
6.25.1 Aviva Systems Biology Company Information
6.25.2 Aviva Systems Biology Description and Business Overview
6.25.3 Aviva Systems Biology HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Aviva Systems Biology HMGB1 Antibody Product Portfolio
6.25.5 Aviva Systems Biology Recent Developments/Updates
6.26 Beijing Solarbio
6.26.1 Beijing Solarbio Company Information
6.26.2 Beijing Solarbio Description and Business Overview
6.26.3 Beijing Solarbio HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Beijing Solarbio HMGB1 Antibody Product Portfolio
6.26.5 Beijing Solarbio Recent Developments/Updates
6.27 Jingjie PTM BioLab
6.27.1 Jingjie PTM BioLab Company Information
6.27.2 Jingjie PTM BioLab Description and Business Overview
6.27.3 Jingjie PTM BioLab HMGB1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Jingjie PTM BioLab HMGB1 Antibody Product Portfolio
6.27.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HMGB1 Antibody Industry Chain Analysis
7.2 HMGB1 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HMGB1 Antibody Production Mode & Process Analysis
7.4 HMGB1 Antibody Sales and Marketing
7.4.1 HMGB1 Antibody Sales Channels
7.4.2 HMGB1 Antibody Distributors
7.5 HMGB1 Antibody Customer Analysis
8 HMGB1 Antibody Market Dynamics
8.1 HMGB1 Antibody Industry Trends
8.2 HMGB1 Antibody Market Drivers
8.3 HMGB1 Antibody Market Challenges
8.4 HMGB1 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global HMGB1 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global HMGB1 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global HMGB1 Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global HMGB1 Antibody Sales (L) of Key Manufacturers (2020-2025)
Table 5. Global HMGB1 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global HMGB1 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global HMGB1 Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market HMGB1 Antibody Average Price (US$/L) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of HMGB1 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of HMGB1 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of HMGB1 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of HMGB1 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global HMGB1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HMGB1 Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global HMGB1 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global HMGB1 Antibody Sales by Region (2020-2025) & (L)
Table 18. Global HMGB1 Antibody Sales Market Share by Region (2020-2025)
Table 19. Global HMGB1 Antibody Sales by Region (2026-2031) & (L)
Table 20. Global HMGB1 Antibody Sales Market Share by Region (2026-2031)
Table 21. Global HMGB1 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global HMGB1 Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global HMGB1 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global HMGB1 Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America HMGB1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America HMGB1 Antibody Sales by Country (2020-2025) & (L)
Table 27. North America HMGB1 Antibody Sales by Country (2026-2031) & (L)
Table 28. North America HMGB1 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America HMGB1 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe HMGB1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe HMGB1 Antibody Sales by Country (2020-2025) & (L)
Table 32. Europe HMGB1 Antibody Sales by Country (2026-2031) & (L)
Table 33. Europe HMGB1 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe HMGB1 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific HMGB1 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific HMGB1 Antibody Sales by Region (2020-2025) & (L)
Table 37. Asia Pacific HMGB1 Antibody Sales by Region (2026-2031) & (L)
Table 38. Asia Pacific HMGB1 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific HMGB1 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America HMGB1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America HMGB1 Antibody Sales by Country (2020-2025) & (L)
Table 42. Latin America HMGB1 Antibody Sales by Country (2026-2031) & (L)
Table 43. Latin America HMGB1 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America HMGB1 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa HMGB1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa HMGB1 Antibody Sales by Country (2020-2025) & (L)
Table 47. Middle East and Africa HMGB1 Antibody Sales by Country (2026-2031) & (L)
Table 48. Middle East and Africa HMGB1 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa HMGB1 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global HMGB1 Antibody Sales (L) by Type (2020-2025)
Table 51. Global HMGB1 Antibody Sales (L) by Type (2026-2031)
Table 52. Global HMGB1 Antibody Sales Market Share by Type (2020-2025)
Table 53. Global HMGB1 Antibody Sales Market Share by Type (2026-2031)
Table 54. Global HMGB1 Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global HMGB1 Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global HMGB1 Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global HMGB1 Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global HMGB1 Antibody Price (US$/L) by Type (2020-2025)
Table 59. Global HMGB1 Antibody Price (US$/L) by Type (2026-2031)
Table 60. Global HMGB1 Antibody Sales (L) by Application (2020-2025)
Table 61. Global HMGB1 Antibody Sales (L) by Application (2026-2031)
Table 62. Global HMGB1 Antibody Sales Market Share by Application (2020-2025)
Table 63. Global HMGB1 Antibody Sales Market Share by Application (2026-2031)
Table 64. Global HMGB1 Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global HMGB1 Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global HMGB1 Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global HMGB1 Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global HMGB1 Antibody Price (US$/L) by Application (2020-2025)
Table 69. Global HMGB1 Antibody Price (US$/L) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. Merck HMGB1 Antibody Product
Table 74. Merck Recent Developments/Updates
Table 75. Thermo Fisher Scientific Company Information
Table 76. Thermo Fisher Scientific Description and Business Overview
Table 77. Thermo Fisher Scientific HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. Thermo Fisher Scientific HMGB1 Antibody Product
Table 79. Thermo Fisher Scientific Recent Developments/Updates
Table 80. Novus Biologicals Company Information
Table 81. Novus Biologicals Description and Business Overview
Table 82. Novus Biologicals HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Novus Biologicals HMGB1 Antibody Product
Table 84. Novus Biologicals Recent Developments/Updates
Table 85. Abbexa Company Information
Table 86. Abbexa Description and Business Overview
Table 87. Abbexa HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 88. Abbexa HMGB1 Antibody Product
Table 89. Abbexa Recent Developments/Updates
Table 90. LifeSpan BioSciences Company Information
Table 91. LifeSpan BioSciences Description and Business Overview
Table 92. LifeSpan BioSciences HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 93. LifeSpan BioSciences HMGB1 Antibody Product
Table 94. LifeSpan BioSciences Recent Developments/Updates
Table 95. GeneTex Company Information
Table 96. GeneTex Description and Business Overview
Table 97. GeneTex HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 98. GeneTex HMGB1 Antibody Product
Table 99. GeneTex Recent Developments/Updates
Table 100. Bio-Rad Company Information
Table 101. Bio-Rad Description and Business Overview
Table 102. Bio-Rad HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 103. Bio-Rad HMGB1 Antibody Product
Table 104. Bio-Rad Recent Developments/Updates
Table 105. Bioss Company Information
Table 106. Bioss Description and Business Overview
Table 107. Bioss HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 108. Bioss HMGB1 Antibody Product
Table 109. Bioss Recent Developments/Updates
Table 110. Chondrex Company Information
Table 111. Chondrex Description and Business Overview
Table 112. Chondrex HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 113. Chondrex HMGB1 Antibody Product
Table 114. Chondrex Recent Developments/Updates
Table 115. Biorbyt Company Information
Table 116. Biorbyt Description and Business Overview
Table 117. Biorbyt HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 118. Biorbyt HMGB1 Antibody Product
Table 119. Biorbyt Recent Developments/Updates
Table 120. Abnova Corporation Company Information
Table 121. Abnova Corporation Description and Business Overview
Table 122. Abnova Corporation HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 123. Abnova Corporation HMGB1 Antibody Product
Table 124. Abnova Corporation Recent Developments/Updates
Table 125. Abeomics Company Information
Table 126. Abeomics Description and Business Overview
Table 127. Abeomics HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 128. Abeomics HMGB1 Antibody Product
Table 129. Abeomics Recent Developments/Updates
Table 130. Abcam Company Information
Table 131. Abcam Description and Business Overview
Table 132. Abcam HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 133. Abcam HMGB1 Antibody Product
Table 134. Abcam Recent Developments/Updates
Table 135. RayBiotech Company Information
Table 136. RayBiotech Description and Business Overview
Table 137. RayBiotech HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 138. RayBiotech HMGB1 Antibody Product
Table 139. RayBiotech Recent Developments/Updates
Table 140. EpiGentek Company Information
Table 141. EpiGentek Description and Business Overview
Table 142. EpiGentek HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 143. EpiGentek HMGB1 Antibody Product
Table 144. EpiGentek Recent Developments/Updates
Table 145. NSJ Bioreagents Company Information
Table 146. NSJ Bioreagents Description and Business Overview
Table 147. NSJ Bioreagents HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 148. NSJ Bioreagents HMGB1 Antibody Product
Table 149. NSJ Bioreagents Recent Developments/Updates
Table 150. ProSci Company Information
Table 151. ProSci Description and Business Overview
Table 152. ProSci HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 153. ProSci HMGB1 Antibody Product
Table 154. ProSci Recent Developments/Updates
Table 155. BioLegend Company Information
Table 156. BioLegend Description and Business Overview
Table 157. BioLegend HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 158. BioLegend HMGB1 Antibody Product
Table 159. BioLegend Recent Developments/Updates
Table 160. HUABIO Company Information
Table 161. HUABIO Description and Business Overview
Table 162. HUABIO HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 163. HUABIO HMGB1 Antibody Product
Table 164. HUABIO Recent Developments/Updates
Table 165. Elabscience Biotechnology Company Information
Table 166. Elabscience Biotechnology Description and Business Overview
Table 167. Elabscience Biotechnology HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 168. Elabscience Biotechnology HMGB1 Antibody Product
Table 169. Elabscience Biotechnology Recent Developments/Updates
Table 170. Enzo Life Sciences Company Information
Table 171. Enzo Life Sciences Description and Business Overview
Table 172. Enzo Life Sciences HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 173. Enzo Life Sciences HMGB1 Antibody Product
Table 174. Enzo Life Sciences Recent Developments/Updates
Table 175. AssayPro Company Information
Table 176. AssayPro Description and Business Overview
Table 177. AssayPro HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 178. AssayPro HMGB1 Antibody Product
Table 179. AssayPro Recent Developments/Updates
Table 180. Cell Signaling Technology Company Information
Table 181. Cell Signaling Technology Description and Business Overview
Table 182. Cell Signaling Technology HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 183. Cell Signaling Technology HMGB1 Antibody Product
Table 184. Cell Signaling Technology Recent Developments/Updates
Table 185. R and D Systems Company Information
Table 186. R and D Systems Description and Business Overview
Table 187. R and D Systems HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 188. R and D Systems HMGB1 Antibody Product
Table 189. R and D Systems Recent Developments/Updates
Table 190. Aviva Systems Biology Company Information
Table 191. Aviva Systems Biology Description and Business Overview
Table 192. Aviva Systems Biology HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 193. Aviva Systems Biology HMGB1 Antibody Product
Table 194. Aviva Systems Biology Recent Developments/Updates
Table 195. Beijing Solarbio Company Information
Table 196. Beijing Solarbio Description and Business Overview
Table 197. Beijing Solarbio HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 198. Beijing Solarbio HMGB1 Antibody Product
Table 199. Beijing Solarbio Recent Developments/Updates
Table 200. Jingjie PTM BioLab Company Information
Table 201. Jingjie PTM BioLab Description and Business Overview
Table 202. Jingjie PTM BioLab HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 203. Jingjie PTM BioLab HMGB1 Antibody Product
Table 204. Jingjie PTM BioLab Recent Developments/Updates
Table 205. Key Raw Materials Lists
Table 206. Raw Materials Key Suppliers Lists
Table 207. HMGB1 Antibody Distributors List
Table 208. HMGB1 Antibody Customers List
Table 209. HMGB1 Antibody Market Trends
Table 210. HMGB1 Antibody Market Drivers
Table 211. HMGB1 Antibody Market Challenges
Table 212. HMGB1 Antibody Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
Table 216. Authors List of This Report
List of Figures
Figure 1. Product Picture of HMGB1 Antibody
Figure 2. Global HMGB1 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HMGB1 Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global HMGB1 Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global HMGB1 Antibody Market Share by Application: 2024 & 2031
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Western Blot (WB)
Figure 11. Immunocytochemistry (ICC)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global HMGB1 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global HMGB1 Antibody Market Size (2020-2031) & (US$ Million)
Figure 16. Global HMGB1 Antibody Sales (2020-2031) & (L)
Figure 17. Global HMGB1 Antibody Average Price (US$/L) & (2020-2031)
Figure 18. HMGB1 Antibody Report Years Considered
Figure 19. HMGB1 Antibody Sales Share by Manufacturers in 2024
Figure 20. Global HMGB1 Antibody Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest HMGB1 Antibody Players: Market Share by Revenue in HMGB1 Antibody in 2024
Figure 22. HMGB1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global HMGB1 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America HMGB1 Antibody Sales Market Share by Country (2020-2031)
Figure 25. North America HMGB1 Antibody Revenue Market Share by Country (2020-2031)
Figure 26. United States HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe HMGB1 Antibody Sales Market Share by Country (2020-2031)
Figure 29. Europe HMGB1 Antibody Revenue Market Share by Country (2020-2031)
Figure 30. Germany HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific HMGB1 Antibody Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific HMGB1 Antibody Revenue Market Share by Region (2020-2031)
Figure 37. China HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America HMGB1 Antibody Sales Market Share by Country (2020-2031)
Figure 45. Latin America HMGB1 Antibody Revenue Market Share by Country (2020-2031)
Figure 46. Mexico HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa HMGB1 Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa HMGB1 Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of HMGB1 Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of HMGB1 Antibody by Type (2020-2031)
Figure 56. Global HMGB1 Antibody Price (US$/L) by Type (2020-2031)
Figure 57. Global Sales Market Share of HMGB1 Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of HMGB1 Antibody by Application (2020-2031)
Figure 59. Global HMGB1 Antibody Price (US$/L) by Application (2020-2031)
Figure 60. HMGB1 Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global HMGB1 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global HMGB1 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global HMGB1 Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global HMGB1 Antibody Sales (L) of Key Manufacturers (2020-2025)
Table 5. Global HMGB1 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global HMGB1 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global HMGB1 Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market HMGB1 Antibody Average Price (US$/L) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of HMGB1 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of HMGB1 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of HMGB1 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of HMGB1 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global HMGB1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HMGB1 Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global HMGB1 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global HMGB1 Antibody Sales by Region (2020-2025) & (L)
Table 18. Global HMGB1 Antibody Sales Market Share by Region (2020-2025)
Table 19. Global HMGB1 Antibody Sales by Region (2026-2031) & (L)
Table 20. Global HMGB1 Antibody Sales Market Share by Region (2026-2031)
Table 21. Global HMGB1 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global HMGB1 Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global HMGB1 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global HMGB1 Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America HMGB1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America HMGB1 Antibody Sales by Country (2020-2025) & (L)
Table 27. North America HMGB1 Antibody Sales by Country (2026-2031) & (L)
Table 28. North America HMGB1 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America HMGB1 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe HMGB1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe HMGB1 Antibody Sales by Country (2020-2025) & (L)
Table 32. Europe HMGB1 Antibody Sales by Country (2026-2031) & (L)
Table 33. Europe HMGB1 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe HMGB1 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific HMGB1 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific HMGB1 Antibody Sales by Region (2020-2025) & (L)
Table 37. Asia Pacific HMGB1 Antibody Sales by Region (2026-2031) & (L)
Table 38. Asia Pacific HMGB1 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific HMGB1 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America HMGB1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America HMGB1 Antibody Sales by Country (2020-2025) & (L)
Table 42. Latin America HMGB1 Antibody Sales by Country (2026-2031) & (L)
Table 43. Latin America HMGB1 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America HMGB1 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa HMGB1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa HMGB1 Antibody Sales by Country (2020-2025) & (L)
Table 47. Middle East and Africa HMGB1 Antibody Sales by Country (2026-2031) & (L)
Table 48. Middle East and Africa HMGB1 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa HMGB1 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global HMGB1 Antibody Sales (L) by Type (2020-2025)
Table 51. Global HMGB1 Antibody Sales (L) by Type (2026-2031)
Table 52. Global HMGB1 Antibody Sales Market Share by Type (2020-2025)
Table 53. Global HMGB1 Antibody Sales Market Share by Type (2026-2031)
Table 54. Global HMGB1 Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global HMGB1 Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global HMGB1 Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global HMGB1 Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global HMGB1 Antibody Price (US$/L) by Type (2020-2025)
Table 59. Global HMGB1 Antibody Price (US$/L) by Type (2026-2031)
Table 60. Global HMGB1 Antibody Sales (L) by Application (2020-2025)
Table 61. Global HMGB1 Antibody Sales (L) by Application (2026-2031)
Table 62. Global HMGB1 Antibody Sales Market Share by Application (2020-2025)
Table 63. Global HMGB1 Antibody Sales Market Share by Application (2026-2031)
Table 64. Global HMGB1 Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global HMGB1 Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global HMGB1 Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global HMGB1 Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global HMGB1 Antibody Price (US$/L) by Application (2020-2025)
Table 69. Global HMGB1 Antibody Price (US$/L) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. Merck HMGB1 Antibody Product
Table 74. Merck Recent Developments/Updates
Table 75. Thermo Fisher Scientific Company Information
Table 76. Thermo Fisher Scientific Description and Business Overview
Table 77. Thermo Fisher Scientific HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. Thermo Fisher Scientific HMGB1 Antibody Product
Table 79. Thermo Fisher Scientific Recent Developments/Updates
Table 80. Novus Biologicals Company Information
Table 81. Novus Biologicals Description and Business Overview
Table 82. Novus Biologicals HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Novus Biologicals HMGB1 Antibody Product
Table 84. Novus Biologicals Recent Developments/Updates
Table 85. Abbexa Company Information
Table 86. Abbexa Description and Business Overview
Table 87. Abbexa HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 88. Abbexa HMGB1 Antibody Product
Table 89. Abbexa Recent Developments/Updates
Table 90. LifeSpan BioSciences Company Information
Table 91. LifeSpan BioSciences Description and Business Overview
Table 92. LifeSpan BioSciences HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 93. LifeSpan BioSciences HMGB1 Antibody Product
Table 94. LifeSpan BioSciences Recent Developments/Updates
Table 95. GeneTex Company Information
Table 96. GeneTex Description and Business Overview
Table 97. GeneTex HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 98. GeneTex HMGB1 Antibody Product
Table 99. GeneTex Recent Developments/Updates
Table 100. Bio-Rad Company Information
Table 101. Bio-Rad Description and Business Overview
Table 102. Bio-Rad HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 103. Bio-Rad HMGB1 Antibody Product
Table 104. Bio-Rad Recent Developments/Updates
Table 105. Bioss Company Information
Table 106. Bioss Description and Business Overview
Table 107. Bioss HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 108. Bioss HMGB1 Antibody Product
Table 109. Bioss Recent Developments/Updates
Table 110. Chondrex Company Information
Table 111. Chondrex Description and Business Overview
Table 112. Chondrex HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 113. Chondrex HMGB1 Antibody Product
Table 114. Chondrex Recent Developments/Updates
Table 115. Biorbyt Company Information
Table 116. Biorbyt Description and Business Overview
Table 117. Biorbyt HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 118. Biorbyt HMGB1 Antibody Product
Table 119. Biorbyt Recent Developments/Updates
Table 120. Abnova Corporation Company Information
Table 121. Abnova Corporation Description and Business Overview
Table 122. Abnova Corporation HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 123. Abnova Corporation HMGB1 Antibody Product
Table 124. Abnova Corporation Recent Developments/Updates
Table 125. Abeomics Company Information
Table 126. Abeomics Description and Business Overview
Table 127. Abeomics HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 128. Abeomics HMGB1 Antibody Product
Table 129. Abeomics Recent Developments/Updates
Table 130. Abcam Company Information
Table 131. Abcam Description and Business Overview
Table 132. Abcam HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 133. Abcam HMGB1 Antibody Product
Table 134. Abcam Recent Developments/Updates
Table 135. RayBiotech Company Information
Table 136. RayBiotech Description and Business Overview
Table 137. RayBiotech HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 138. RayBiotech HMGB1 Antibody Product
Table 139. RayBiotech Recent Developments/Updates
Table 140. EpiGentek Company Information
Table 141. EpiGentek Description and Business Overview
Table 142. EpiGentek HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 143. EpiGentek HMGB1 Antibody Product
Table 144. EpiGentek Recent Developments/Updates
Table 145. NSJ Bioreagents Company Information
Table 146. NSJ Bioreagents Description and Business Overview
Table 147. NSJ Bioreagents HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 148. NSJ Bioreagents HMGB1 Antibody Product
Table 149. NSJ Bioreagents Recent Developments/Updates
Table 150. ProSci Company Information
Table 151. ProSci Description and Business Overview
Table 152. ProSci HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 153. ProSci HMGB1 Antibody Product
Table 154. ProSci Recent Developments/Updates
Table 155. BioLegend Company Information
Table 156. BioLegend Description and Business Overview
Table 157. BioLegend HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 158. BioLegend HMGB1 Antibody Product
Table 159. BioLegend Recent Developments/Updates
Table 160. HUABIO Company Information
Table 161. HUABIO Description and Business Overview
Table 162. HUABIO HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 163. HUABIO HMGB1 Antibody Product
Table 164. HUABIO Recent Developments/Updates
Table 165. Elabscience Biotechnology Company Information
Table 166. Elabscience Biotechnology Description and Business Overview
Table 167. Elabscience Biotechnology HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 168. Elabscience Biotechnology HMGB1 Antibody Product
Table 169. Elabscience Biotechnology Recent Developments/Updates
Table 170. Enzo Life Sciences Company Information
Table 171. Enzo Life Sciences Description and Business Overview
Table 172. Enzo Life Sciences HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 173. Enzo Life Sciences HMGB1 Antibody Product
Table 174. Enzo Life Sciences Recent Developments/Updates
Table 175. AssayPro Company Information
Table 176. AssayPro Description and Business Overview
Table 177. AssayPro HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 178. AssayPro HMGB1 Antibody Product
Table 179. AssayPro Recent Developments/Updates
Table 180. Cell Signaling Technology Company Information
Table 181. Cell Signaling Technology Description and Business Overview
Table 182. Cell Signaling Technology HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 183. Cell Signaling Technology HMGB1 Antibody Product
Table 184. Cell Signaling Technology Recent Developments/Updates
Table 185. R and D Systems Company Information
Table 186. R and D Systems Description and Business Overview
Table 187. R and D Systems HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 188. R and D Systems HMGB1 Antibody Product
Table 189. R and D Systems Recent Developments/Updates
Table 190. Aviva Systems Biology Company Information
Table 191. Aviva Systems Biology Description and Business Overview
Table 192. Aviva Systems Biology HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 193. Aviva Systems Biology HMGB1 Antibody Product
Table 194. Aviva Systems Biology Recent Developments/Updates
Table 195. Beijing Solarbio Company Information
Table 196. Beijing Solarbio Description and Business Overview
Table 197. Beijing Solarbio HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 198. Beijing Solarbio HMGB1 Antibody Product
Table 199. Beijing Solarbio Recent Developments/Updates
Table 200. Jingjie PTM BioLab Company Information
Table 201. Jingjie PTM BioLab Description and Business Overview
Table 202. Jingjie PTM BioLab HMGB1 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 203. Jingjie PTM BioLab HMGB1 Antibody Product
Table 204. Jingjie PTM BioLab Recent Developments/Updates
Table 205. Key Raw Materials Lists
Table 206. Raw Materials Key Suppliers Lists
Table 207. HMGB1 Antibody Distributors List
Table 208. HMGB1 Antibody Customers List
Table 209. HMGB1 Antibody Market Trends
Table 210. HMGB1 Antibody Market Drivers
Table 211. HMGB1 Antibody Market Challenges
Table 212. HMGB1 Antibody Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
Table 216. Authors List of This Report
List of Figures
Figure 1. Product Picture of HMGB1 Antibody
Figure 2. Global HMGB1 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HMGB1 Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global HMGB1 Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global HMGB1 Antibody Market Share by Application: 2024 & 2031
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Western Blot (WB)
Figure 11. Immunocytochemistry (ICC)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global HMGB1 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global HMGB1 Antibody Market Size (2020-2031) & (US$ Million)
Figure 16. Global HMGB1 Antibody Sales (2020-2031) & (L)
Figure 17. Global HMGB1 Antibody Average Price (US$/L) & (2020-2031)
Figure 18. HMGB1 Antibody Report Years Considered
Figure 19. HMGB1 Antibody Sales Share by Manufacturers in 2024
Figure 20. Global HMGB1 Antibody Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest HMGB1 Antibody Players: Market Share by Revenue in HMGB1 Antibody in 2024
Figure 22. HMGB1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global HMGB1 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America HMGB1 Antibody Sales Market Share by Country (2020-2031)
Figure 25. North America HMGB1 Antibody Revenue Market Share by Country (2020-2031)
Figure 26. United States HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe HMGB1 Antibody Sales Market Share by Country (2020-2031)
Figure 29. Europe HMGB1 Antibody Revenue Market Share by Country (2020-2031)
Figure 30. Germany HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific HMGB1 Antibody Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific HMGB1 Antibody Revenue Market Share by Region (2020-2031)
Figure 37. China HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America HMGB1 Antibody Sales Market Share by Country (2020-2031)
Figure 45. Latin America HMGB1 Antibody Revenue Market Share by Country (2020-2031)
Figure 46. Mexico HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa HMGB1 Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa HMGB1 Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE HMGB1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of HMGB1 Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of HMGB1 Antibody by Type (2020-2031)
Figure 56. Global HMGB1 Antibody Price (US$/L) by Type (2020-2031)
Figure 57. Global Sales Market Share of HMGB1 Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of HMGB1 Antibody by Application (2020-2031)
Figure 59. Global HMGB1 Antibody Price (US$/L) by Application (2020-2031)
Figure 60. HMGB1 Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232